People with obesity who take weight loss and diabetes drugs like Ozempic and Mounjaro could face a lower risk of cancer compared to those with obesity who do not. Looking at 14 cancers, of which 13 ...

Ozempic and other GLP-1 weight-loss medications are seeing explosive growth in popularity, but they’re also facing billions ...

More than 40 years ago, Apollonia Kotero met Prince when she auditioned to play his love interest in 1984’s Purple Rain. She ...

Serena Williams has faced speculation of using Ozempic to lose weight, but the tennis legend credits her 31-pound ...

Joseph Radhik, a renowned wedding photographer, shared his three-year fitness journey on Instagram, showcasing his ...

Dr Shazia Malik - a consultant obstetrician and gynaecologist for The Portland Hospital - discussed the pros and cons of ...

A Comeback Fueled by Resilience Danish pharmaceutical giant Novo Nordisk (NYSE:NVO) has been a trailblazer in the GLP-1 drug ...

Fans rubbed their eyes in disbelief after Meghan Trainor shared a video of herself attempting a wild and risky challenge ...

Tennis star Serena Williams' candor about her GLP-1 use may help dispel the pesky health inaccuracy that weight loss is a simple matter of exercise.

In the wake of weight-loss drugs and the rising importance of health, the iconic cultural brand must double down on its roots ...

Serena Williams is promoting GLP-1 drugs from Ro.co, which have been met with brutal criticism from many fans.

GLP-1 drugs for diabetes and weight loss may influence patients’ cancer risk, usually lowering it but sometimes possibly increasing it, new findings suggest.